TRUL Stock Overview
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for TRUL from our risk checks.
My Notes
NewNotes are coming soon
Trulieve Cannabis Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$8.54 |
52 Week High | CA$34.55 |
52 Week Low | CA$8.08 |
Beta | 1.86 |
1 Month Change | -16.76% |
3 Month Change | -46.22% |
1 Year Change | -64.04% |
3 Year Change | -40.45% |
5 Year Change | n/a |
Change since IPO | -14.43% |
Recent News & Updates
Recent updates
These 4 Measures Indicate That Trulieve Cannabis (CSE:TRUL) Is Using Debt Extensively
Jan 26Does Trulieve Cannabis (CSE:TRUL) Have A Healthy Balance Sheet?
Aug 07Are Trulieve Cannabis Corp. (CSE:TRUL) Investors Paying Above The Intrinsic Value?
Jul 03These 4 Measures Indicate That Trulieve Cannabis (CSE:TRUL) Is Using Debt Reasonably Well
Mar 21Is Trulieve Cannabis (CSE:TRUL) Using Too Much Debt?
Aug 16With EPS Growth And More, Trulieve Cannabis (CSE:TRUL) Is Interesting
Jun 08Is Trulieve Cannabis (CSE:TRUL) Using Too Much Debt?
Apr 07Did Trulieve Cannabis Corp. (CSE:TRUL) Insiders Sell Shares?
Mar 03Is Trulieve Cannabis Corp. (CSE:TRUL) Trading At A 48% Discount?
Feb 16Is Trulieve Cannabis Corp.'s(CSE:TRUL) Recent Stock Performance Tethered To Its Strong Fundamentals?
Feb 02Could The Trulieve Cannabis Corp. (CSE:TRUL) Ownership Structure Tell Us Something Useful?
Jan 15Investors Who Bought Trulieve Cannabis (CSE:TRUL) Shares A Year Ago Are Now Up 186%
Dec 16Trade Alert: The Director Of Trulieve Cannabis Corp. (CSE:TRUL), Susan Thronson, Has Just Spent US$64k Buying 65% More Shares
Nov 27Trulieve Cannabis Corp. Just Missed Earnings - But Analysts Have Updated Their Models
Nov 19If You Like EPS Growth Then Check Out Trulieve Cannabis (CSE:TRUL) Before It's Too Late
Nov 17Can You Imagine How Trulieve Cannabis' (CSE:TRUL) Shareholders Feel About The 47% Share Price Increase?
Jul 13Shareholder Returns
TRUL | CA Pharmaceuticals | CA Market | |
---|---|---|---|
7D | -6.2% | -3.7% | 0.6% |
1Y | -64.0% | -59.1% | -0.6% |
Return vs Industry: TRUL underperformed the Canadian Pharmaceuticals industry which returned -59.1% over the past year.
Return vs Market: TRUL underperformed the Canadian Market which returned -0.6% over the past year.
Price Volatility
TRUL volatility | |
---|---|
TRUL Average Weekly Movement | 12.2% |
Pharmaceuticals Industry Average Movement | 14.2% |
Market Average Movement | 9.9% |
10% most volatile stocks in CA Market | 19.2% |
10% least volatile stocks in CA Market | 3.9% |
Stable Share Price: TRUL is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: TRUL's weekly volatility (12%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1940 | 8,000 | Kim Rivers | https://www.trulieve.com |
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. It cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. The company produces flower, edible, vaporizer cartridge, concentrate, topical, capsule, tincture, dissolvable powder, and nasal spray products under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One brands.
Trulieve Cannabis Corp. Fundamentals Summary
TRUL fundamental statistics | |
---|---|
Market Cap | CA$1.59b |
Earnings (TTM) | -CA$263.90m |
Revenue (TTM) | CA$1.65b |
1.0x
P/S Ratio-6.0x
P/E RatioIs TRUL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
TRUL income statement (TTM) | |
---|---|
Revenue | US$1.24b |
Cost of Revenue | US$537.00m |
Gross Profit | US$705.96m |
Other Expenses | US$904.19m |
Earnings | -US$198.23m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -1.07 |
Gross Margin | 56.80% |
Net Profit Margin | -15.95% |
Debt/Equity Ratio | 27.5% |
How did TRUL perform over the long term?
See historical performance and comparison